Hepion Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding from Q3 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Hepion Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q3 2012 to Q3 2024.
  • Hepion Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 6.96M shares, a 81.3% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 6.96M +3.12M +81.3% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 5.8M +1.96M +51.1% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 5.47M +1.66M +43.6% Mar 31, 2024 10-Q 2024-05-21
Q4 2023 4.82M +1.01M +26.4% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 3.84M -72.4M -95% Sep 30, 2023 10-Q 2023-11-20
Q2 2023 3.84M -72.4M -95% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 3.81M -72.4M -95% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 3.81M -72.4M -95% Dec 31, 2022 10-K 2024-04-16
Q3 2022 76.2M +4.36K +0.01% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 76.2M +4.37K +0.01% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 76.2M +4.37K +0.01% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 76.2M +44.2M +138% Dec 31, 2021 10-K 2023-04-10
Q3 2021 76.2M +67.2M +745% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 76.2M +67.2M +745% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 76.2M +70.2M +1155% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 32M +28.3M +752% Dec 31, 2020 10-K 2022-04-08
Q3 2020 9.03M +5.57M +161% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 9.03M +5.57M +161% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 6.07M -14.7M -70.8% Mar 31, 2020 10-Q 2020-06-30
Q4 2019 3.76M +3.51M +1422% Dec 31, 2019 10-K 2021-03-31
Q3 2019 3.45M -12.9M -78.8% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 3.45M -7.24M -67.7% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 20.8M -64.2M -75.5% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 247K -9.55M -97.5% Dec 31, 2018 10-K 2020-05-14
Q3 2018 16.3M -61.9M -79.1% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 10.7M -65M -85.9% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 85M +21.2M +33.3% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 9.79M -53M -84.4% Dec 31, 2017 10-K 2019-03-14
Q3 2017 78.2M +22.6M +40.6% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 75.7M +43.5M +135% Jun 30, 2017 10-KT 2018-03-26
Q1 2017 63.7M +36.4M +133% Mar 31, 2017 10-Q 2017-04-12
Q4 2016 62.8M +35.5M +130% Dec 31, 2016 10-Q 2017-02-14
Q3 2016 55.6M +33.3M +149% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 32.2M +9.95M +44.7% Jun 30, 2016 10-KT 2018-03-26
Q1 2016 27.3M +5.03M +22.6% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 27.3M +5.02M +22.5% Dec 31, 2015 10-Q 2016-02-12
Q3 2015 22.3M +57.7K +0.26% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 22.3M +3.8M +20.6% Jun 30, 2015 10-K 2016-09-28
Q1 2015 22.3M +13.3M +147% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 22.3M +13.3M +147% Dec 31, 2014 10-Q 2015-02-12
Q3 2014 22.2M +13.2M +147% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 18.5M +9.48M +105% Jun 30, 2014 10-K 2015-09-25
Q1 2014 9M Mar 31, 2014 10-Q 2015-05-14
Q4 2013 9M Dec 31, 2013 10-Q 2015-02-12
Q3 2013 9M 0 0% Sep 30, 2013 10-Q 2013-11-19
Q2 2013 9M Jun 30, 2013 10-K 2014-09-29
Q3 2012 9M Aug 17, 2012 10-K 2015-09-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.